SpringWorks Therapeutics, Inc. Common Stock (SWTX) is a publicly traded Healthcare sector company. As of May 20, 2026, SWTX trades at $46.99 with a market cap of $3.48B and a P/E ratio of -13.78. SWTX moved +0.00% today. Year to date, SWTX is +29.45%; over the trailing twelve months it is +25.21%. Its 52-week range spans $28.21 to $62.00. Analyst consensus is buy with an average price target of $47.00. Rallies surfaces SWTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own SWTX include Duquesne Family. The latest tracked quarter is Mar 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for SpringWorks Therapeutics, Inc. Common Stock.
| Metric | Value |
|---|---|
| Price | $46.99 |
| Market Cap | $3.48B |
| P/E Ratio | -13.78 |
| EPS | $-3.41 |
| Dividend Yield | 0.00% |
| 52-Week High | $62.00 |
| 52-Week Low | $28.21 |
| Volume | 5.01M |
| Avg Volume | 0 |
| Revenue (TTM) | $219.67M |
| Net Income | $-253.93M |
| Gross Margin | 93.23% |
11 analysts cover SWTX: 0 strong buy, 7 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $47.00.